Translate this website into the following languages:

Close Tab
UC San Diego Health
menu iconMenu
search iconSearch

Ferrara Receives Gairdner Prize, Canada’s Highest Honor in Life Sciences

Honored for research leading to new therapies for cancer and wet macular degeneration

March 26, 2014  |  

Napoleone Ferrara, MD, distinguished professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today among eight recipients of the Canada Gairdner Awards at a ceremony in Toronto.


Napoleone Ferrara, MD

The Gairdner awards are among the most esteemed honors in medical research, celebrating  outstanding discoveries or contributions to medical and life sciences. This year’s awards showcase achievements in cardiovascular disease, cancer, immunotherapy and human parasitic diseases.

Ferrara was recognized for his work identifying the role of the human VEGF gene in promoting angiogenesis – the formation of new blood vessels that can feed tumor growth – and subsequent development of two major monoclonal antibody drugs: Bevacizumab (marketed as Avastin), which is used to treat multiple forms of cancer, including breast, brain and colorectal, and ranibizumab (marketed as Lucentis), which treats wet age-related macular degeneration, a leading cause of blindness in the elderly.

Other 2014 recipients are James P. Allison, PhD, of the University of Texas MD Anderson Cancer Center for developing immune system-based cancer therapies; Titia de Lange, PhD, of Rockefeller University for her discovery of the mechanisms protecting mammalian telomeres from damage; Sir Marc Feldman, FRS, and Sir Ravinder Nath Maini, FRS, of the University of Oxford for their discovery of a new rheumatoid arthritis treatment; Harold Fisher Dvorak, MD, of Harvard Medical School for his work describing how cancer tumors make VEGF; Satoshi Omura, PhD, of Kitasato University for identifying the causative microorganisms of  river blindness and helping develop a successful treatment; and Salim Yusuf, MBBS, of David Braley Research Institute for his extensive epidemiological cardiovascular studies in more than 60 countries. 

The Gairdner awards have been presented by the Gairdner Foundation since 1959, and are  sometimes a precursor to later Nobel Prizes. Each award comes with a $100,000 stipend in Canadian dollars. The awards will be formally presented at a dinner in Toronto in late October. 

# # #

Media contact: Scott LaFee, 619-543-6163,

Media Contact

Share This Article

Related News

In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, wri ...
Roger Tsien, PhD, co-winner of the 2008 Nobel Prize in chemistry and professor of pharmacology, chemistry and biochemistry at University of California San Diego School of Medicine for 27 years, died A ...
Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-mi ...
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminatin ...

Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: